Chapel Hill, NC, United States of America

Marcus Mall


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2009-2015

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Marcus Mall

Introduction

Marcus Mall is a prominent inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of biomedical research, particularly in the study of lung diseases. With a total of three patents to his name, Mall's work focuses on developing animal models that can aid in the understanding and treatment of chronic obstructive pulmonary disease and cystic fibrosis.

Latest Patents

One of Mall's latest patents describes a nonhuman transgenic mammal whose genome includes a promoter construct linked to a heterologous DNA encoding an epithelial sodium channel β subunit. This innovative model directs the expression of the epithelial sodium channel β subunit in lung epithelial cells. The transgenic mammal exhibits increased lung mucus retention compared to its wild-type counterparts. This animal model is particularly useful for screening compounds aimed at treating lung diseases such as cystic fibrosis and chronic obstructive pulmonary disease.

Career Highlights

Marcus Mall is affiliated with the University of North Carolina at Chapel Hill, where he conducts his research. His work has garnered attention for its potential to revolutionize the way lung diseases are studied and treated. His innovative approaches have positioned him as a key figure in the field of respiratory medicine.

Collaborations

Mall collaborates with notable colleagues, including Richard C. Boucher and Wanda Kay O'Neal. These partnerships enhance the research efforts and contribute to the advancement of knowledge in the field.

Conclusion

Marcus Mall's contributions to the development of animal models for lung diseases highlight his innovative spirit and dedication to biomedical research. His work not only furthers scientific understanding but also holds promise for future therapeutic advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…